Pharmaceuticals, Biotechnology and Life Sciences
Financing led by DreamCIS will accelerate and expand development of the company’s industry-leading integrated platform, combining human iPSC-derived cells, advanced…
Partnership unites advanced screening solutions with world-class small molecule libraries. CHICAGO–(BUSINESS WIRE)–#AssayDevelopment—Peapod Bio Inc., a leader in innovative assay development…
SPID®-Technology utilizes compartmentalization to enable sequential release of carbidopa and levodopa, offering a potential new approach for drug delivery in…
Study approval enables Rett REVOLUTION and Pitt Hopkins clinical programs to commence patient recruitment with first dosing expected in January…
Results of Ontada study to be presented at ASH signals a need to revisit anemia strategies in patients with myelodysplastic…
LANGHORNE, Pa.–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the…
PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that it will highlight new open-label extension data from…
–Data presentations to feature 18-month NAUTILUS results and new Post Approval Study (PAS) analyses on GTC seizure reduction– –RNS® System…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aera Therapeutics, a biotechnology company harnessing next-generation delivery technologies and precision payloads to unlock the full potential of…
LTS-101 is a one-time AAV gene therapy candidate intended to provide durable expression of the TPP1 enzyme in the central…